L2M – NexusNeuro Portable EEG Validation

Diagnosing neurological conditions like epilepsy is often difficult because clinicians rely on brief, in-clinic brain activity recordings, which may miss crucial events. To solve this, our company, NexusNeuro, is developing a “Neurological Holter Monitor” — a discreet, wearable EEG device that allows for continuous, long-term brain monitoring in a patient’s everyday environment. While we have the core technology, we need to confirm the best way to bring it to market.

This four-month project is designed to bridge that gap. The goal is to perform a deep market validation study to determine the most urgent clinical need for our device. This will be achieved by conducting over 100 interviews with key stakeholders, including neurologists, sleep specialists, and hospital administrators.

The primary benefit for NexusNeuro will be the creation of a Commercialization Blueprint. This key deliverable will use the data gathered from interviews to define the essential features for our first product, outline a clear go-to-market strategy, and validate our business model. By completing this project, we will transform our innovative idea into an evidence-based business plan, significantly reducing risk and accelerating our path to improving patient care in Canada and beyond.

Faculty Supervisor:

John Griffiths

Student:

Partner:

DMZ Ventures Inc

Discipline:

Business

Sector:

Professional, scientific and technical services

University:

University of Toronto

Program: